FG
BXC icon

Formula Growth’s BlueLinx BXC Stock Holding History

Formula Growth’s Portfolio BXC Stock Details BXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,162
Closed -$765K – 140
2023
Q2 		$765K Sell
8,162
-2,400
-23% -$192K 0.24% 109
2023
Q1 		$718K Sell
10,562
-48,000
-82% -$3.88M 0.23% 113
2022
Q4 		$4.16M Sell
58,562
-14,000
-19% -$954K 1.18% 29
2022
Q3 		$4.51M Buy
72,562
+8,995
+14% +$648K 1.29% 21
2022
Q2 		$4.25M Buy
63,567
+10,009
+19% +$752K 1.18% 31
2022
Q1 		$3.85M Buy
53,558
+25,558
+91% +$2.09M 0.73% 55
2021
Q4 		$2.68M Buy
+28,000
New +$1.9M 0.48% 69

Other funds holding BXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Formula Growth's BXC Position: Q3 2023 in Review

Formula Growth sold out of BlueLinx (BXC) in Q3 2023, closing a stake of 8,162 shares — an estimated $765K sold.

Formula Growth first reported a position in BXC in Q4 2021 and held it in 7 quarters. The position peaked at $4.51M in Q3 2022. 162 funds tracked by Wall St. Rank hold BXC as of Q3 2023.

  • Formula Growth reported no remaining BlueLinx position as of Q3 2023 after selling out during the quarter.
  • Formula Growth sold 8,162 BlueLinx shares in Q3 2023, an estimated $765K.
  • Formula Growth first reported a position in BlueLinx in Q4 2021 and held it in 7 quarters.
  • Formula Growth's BlueLinx position peaked at $4.51M in Q3 2022.
  • 162 funds tracked by Wall St. Rank held BlueLinx as of Q3 2023.

Based on Formula Growth's 13F filing for Q3 2023, filed 13 Nov 2023.